Literature DB >> 24595820

Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Lucina E Lizarraga1, Andy V Phan, Aram B Cholanians, Joseph M Herndon, Serrine S Lau, Terrence J Monks.   

Abstract

3,4-(±)-Methylenedioxymethamphetamine (MDMA) is a ring-substituted amphetamine derivative with potent psychostimulant properties. The neuropharmacological effects of MDMA are biphasic in nature, initially causing synaptic monoamine release, primarily of serotonin (5-HT), inducing thermogenesis and hyperactivity (5-HT syndrome). The long-term effects of MDMA manifest as a prolonged depletion in 5-HT, and structural damage to 5-HT nerve terminals. MDMA toxicity is in part mediated by an ability to inhibit the presynaptic 5-HT reuptake transporter (SERT). Using a SERT-knockout (SERT-KO) rat model, we determined the impact of SERT deficiency on thermoregulation, locomotor activity, and neurotoxicity in SERT-KO or Wistar-based wild-type (WT) rats exposed to MDMA. WT and SERT-KO animals exhibited the highest thermogenic responses to MDMA (four times 10 mg/kg, sc at 12 h intervals) during the diurnal (first and third) doses according to peak body temperature and area under the curve (∑°C × h) analysis. Although no differences in peak body temperature were observed between MDMA-treated WT and SERT-KO animals, ∑°C × h following the first MDMA dose was reduced in SERT-KO rats. Exposure to a single dose of MDMA stimulated horizontal velocity in both WT and SERT-KO rats, however, this effect was delayed and attenuated in the KO animals. Finally, SERT-KO rats were insensitive to MDMA-induced long-term (7 days) depletions in 5-HT and its metabolite, 5-hydroxyindole acetic acid, in both cortex and striatum. In conclusion, SERT deficiency modulated MDMA-mediated thermogenesis, hyperactivity and neurotoxicity in KO rats. The data confirm that the SERT is essential for the manifestation of the acute and long-term toxicities of MDMA.

Entities:  

Keywords:  MDMA; SERT; locomotor activity; neurotoxicity; thermoregulation

Mesh:

Substances:

Year:  2014        PMID: 24595820      PMCID: PMC4031621          DOI: 10.1093/toxsci/kfu039

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  44 in total

Review 1.  Circadian rhythms of body temperature and motor activity in rodents their relationships with the light-dark cycle.

Authors:  C Benstaali; A Mailloux; A Bogdan; A Auzéby; Y Touitou
Journal:  Life Sci       Date:  2001-05-04       Impact factor: 5.037

2.  Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.

Authors:  M E Liechti; C Baumann; A Gamma; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

3.  Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.

Authors:  B T Callahan; B J Cord; G A Ricaurte
Journal:  Synapse       Date:  2001-05       Impact factor: 2.562

4.  Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.

Authors:  Alinde E Wallinga; Carolin Grahlmann; Ramon A Granneman; Jaap M Koolhaas; Bauke Buwalda
Journal:  Brain Res       Date:  2011-05-04       Impact factor: 3.252

5.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

6.  3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

Authors:  José Manuel Trigo; Thibault Renoir; Laurence Lanfumey; Michel Hamon; Klaus-Peter Lesch; Patricia Robledo; Rafael Maldonado
Journal:  Biol Psychiatry       Date:  2007-02-16       Impact factor: 13.382

Review 7.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.

Authors:  G A Ricaurte; J Yuan; U D McCann
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

8.  Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats.

Authors:  Judith R Homberg; Sietse F De Boer; Halfdan S Raasø; Jocelien D A Olivier; Mark Verheul; Eric Ronken; Alexander R Cools; Bart A Ellenbroek; Anton N M Schoffelmeer; Louk J M J Vanderschuren; Taco J De Vries; Edwin Cuppen
Journal:  Psychopharmacology (Berl)       Date:  2008-06-27       Impact factor: 4.530

9.  Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system.

Authors:  J R Homberg; J D A Olivier; B M G Smits; J D Mul; J Mudde; M Verheul; O F M Nieuwenhuizen; A R Cools; E Ronken; T Cremers; A N M Schoffelmeer; B A Ellenbroek; E Cuppen
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

10.  Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  Katsutoshi Shioda; Koichi Nisijima; Tatsuki Yoshino; Kyoko Kuboshima; Tatsunori Iwamura; Kunio Yui; Satoshi Kato
Journal:  Neurotoxicology       Date:  2008-08-05       Impact factor: 4.294

View more
  5 in total

1.  Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.

Authors:  Aram B Cholanians; Andy V Phan; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

2.  Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

Authors:  Lucina E Lizarraga; Aram B Cholanians; Andy V Phan; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-11-04       Impact factor: 4.849

3.  A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours.

Authors:  Bridget W Brox; Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2018-03-21       Impact factor: 4.530

4.  Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment.

Authors:  Philip A Adeniyi; Azeez O Ishola; Babafemi J Laoye; Babawale P Olatunji; Oluwamolakun O Bankole; Philemon D Shallie; Olalekan M Ogundele
Journal:  Metab Brain Dis       Date:  2015-06-20       Impact factor: 3.584

5.  Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats.

Authors:  Ibrahim M Shokry; Connor J Shields; John J Callanan; Zhiyuan Ma; Rui Tao
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-05       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.